United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar wassercom (91.59) Submitted: 2/22/2009 9:15:12 AM : Outperform Start Price: $34.59 UTHR Score: -44.42

Pipeline looks good.

Featured Broker Partners


Advertisement